Tumor clone dynamics in lethal prostate cancer

被引：4

作者：

da Silva, Fernando Calais ^{[1
,2
]}

Oliveira, Pedro ^{[3
,4
]}

机构：

[1] SEUG, Lisbon, Portugal

[2] Av 5 Outubro 72 6 B, Lisbon, Portugal

[3] Christie Hosp, Dept Pathol, Manchester, Lancs, England

[4] Christie NHS Fdn Trust, Wilmslow Rd, Manchester M20 4BX, Lancs, England

来源：

EUROPEAN UROLOGY | 2017年 / 71卷 / 01期

关键词：

D O I：

10.1016/j.eururo.2016.11.001

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：142 / 143

页数：3

共 8 条

[1] Potential Benefits of Intermittent Androgen Suppression Therapy in the Treatment of Prostate Cancer: A Systematic Review of the Literature [J].

Abrahamsson, Per-Anders .

EUROPEAN UROLOGY, 2010, 57 (01) :49-59

[2] Abiraterone and Increased Survival in Metastatic Prostate Cancer [J].

De Bono, Johann S. ;

Logothetis, Christopher J. ;

Molina, Arturo ;

Fizazi, Karim ;

North, Scott ;

Chu, Luis ;

Chi, Kim N. ;

Jones, Robert J. ;

Goodman, Oscar B., Jr. ;

Saad, Fred ;

Staffurth, John N. ;

Mainwaring, Paul ;

Harland, Stephen ;

Flaig, Thomas W. ;

Hutson, Thomas E. ;

Cheng, Tina ;

Patterson, Helen ;

Hainsworth, John D. ;

Ryan, Charles J. ;

Sternberg, Cora N. ;

Ellard, Susan L. ;

Flechon, Aude ;

Saleh, Mansoor ;

Scholz, Mark ;

Efstathiou, Eleni ;

Zivi, Andrea ;

Bianchini, Diletta ;

Loriot, Yohann ;

Chieffo, Nicole ;

Thian Kheoh ;

Haqq, Christopher M. ;

Scher, Howard I. .

NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (21) :1995-2005

[3] A history of prostate cancer treatment [J].

Denmeade, SR ;

Isaacs, JT .

NATURE REVIEWS CANCER, 2002, 2 (05) :389-396

[4] DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer [J].

Mateo, J. ;

Carreira, S. ;

Sandhu, S. ;

Miranda, S. ;

Mossop, H. ;

Perez-Lopez, R. ;

Rodrigues, D. Nava ;

Robinson, D. ;

Omlin, A. ;

Tunariu, N. ;

Boysen, G. ;

Porta, N. ;

Flohr, P. ;

Gillman, A. ;

Figueiredo, I. ;

Paulding, C. ;

Seed, G. ;

Jain, S. ;

Ralph, C. ;

Protheroe, A. ;

Hussain, S. ;

Jones, R. ;

Elliott, T. ;

McGovern, U. ;

Bianchini, D. ;

Goodall, J. ;

Zafeiriou, Z. ;

Williamson, C. T. ;

Ferraldeschi, R. ;

Riisnaes, R. ;

Ebbs, B. ;

Fowler, G. ;

Roda, D. ;

Yuan, W. ;

Wu, Y. -M. ;

Cao, X. ;

Brough, R. ;

Pemberton, H. ;

A'Hern, R. ;

Swain, A. ;

Kunju, L. P. ;

Eeles, R. ;

Attard, G. ;

Lord, C. J. ;

Ashworth, A. ;

Rubin, M. A. ;

Knudsen, K. E. ;

Feng, F. Y. ;

Chinnaiyan, A. M. ;

Hall, E. .

NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (18) :1697-1708

[5] An update on enzalutamide in the treatment of prostate cancer [J].

Merseburger, Axel S. ;

Haas, Gabriel P. ;

von Klot, Christoph-A. .

THERAPEUTIC ADVANCES IN UROLOGY, 2015, 7 (01) :9-21

[6] Resistance to CYP17A1 Inhibition with Abiraterone in Castration-Resistant Prostate Cancer: Induction of Steroidogenesis and Androgen Receptor Splice Variants [J].

Mostaghel, Elahe A. ;

Marck, Brett T. ;

Plymate, Stephen R. ;

Vessella, Robert L. ;

Balk, Stephen ;

Matsumoto, Alvin M. ;

Nelson, Peter S. ;

Montgomery, R. Bruce .

CLINICAL CANCER RESEARCH, 2011, 17 (18) :5913-5925

[7] Molecular States Underlying Androgen Receptor Activation: A Framework for Therapeutics Targeting Androgen Signaling in Prostate Cancer [J].

Nelson, Peter S. .

JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (06) :644-646

[8] Bipolar Androgen Therapy for Men With Androgen Ablation Naive Prostate Cancer: Results From the Phase II BATMAN Study [J].

Schweizer, Michael T. ;

Wang, Hao ;

Luber, Brandon ;

Nadal, Rosa ;

Spitz, Avery ;

Rosen, D. Marc ;

Cao, Haiyi ;

Antonarakis, Emmanuel S. ;

Eisenberger, Mario A. ;

Carducci, Michael A. ;

Paller, Channing ;

Denmeade, Samuel R. .

PROSTATE, 2016, 76 (13) :1218-1226

← 1 →